School of Medicine, University of Nottingham, Nottingham NG7 2RD, UK.
School of Health Sciences, University of East Anglia, NR4 7TJ, UK.
Nicotine Tob Res. 2024 Jan 22;26(2):212-219. doi: 10.1093/ntr/ntad140.
For nonpregnant people unable to quit smoking, the NHS recommends nicotine replacement therapy (NRT) for smoking reduction. This is not recommended during pregnancy due to concerns about higher nicotine intake than smoking alone. We investigated the relationship between daily nicotine dose from NRT and cigarette consumption reported by pregnant women receiving smoking cessation support.
We conducted secondary analysis of data from currently smoking pregnant women, recruited from antenatal clinics (Nottingham University Hospitals, UK) or online between June 2019-September 2020. Participants set a quit date, received a prototype NRT adherence intervention, and reported cigarettes per day (CPD) and daily NRT dose (mg) via smartphone app for 28 days.
388 women were screened, 32 (8%) were eligible and joined the study. 24 (75%) submitted 510 app reports in total. 17 (71%) reported smoking and using NRT concurrently on at least one day, with concurrent use reported on 109 (21%) of app reports.The relationship between daily NRT dose and CPD followed an exponential decay curve of approximately 7%. In multilevel repeated measures modelling using 4 linear splines (knots 17, 40, and 85 mg/NRT), significant fixed effects of daily NRT dose on CPD were observed for splines 1, 3, and 4. The strongest association was spline 1 (0-17 mg/NRT), where each 10 mg NRT increase was associated with a 0.6 CPD reduction (24% on average).
Among women in a cessation study, many smoked and used NRT concurrently; within these women, daily nicotine dose and heaviness of smoking were inversely related.
Findings have implications for the design of future interventions intended to reduce harm associated with smoking in pregnancy. They suggest using NRT alongside smoking in pregnancy could help some women reduce the number of cigarettes they smoke per day.
对于无法戒烟的非孕妇人群,NHS 建议使用尼古丁替代疗法(NRT)来减少吸烟量。由于担心摄入的尼古丁比单独吸烟还要多,因此不建议在怀孕期间使用 NRT。我们调查了接受戒烟支持的孕妇报告的 NRT 日剂量与香烟消耗量之间的关系。
我们对 2019 年 6 月至 2020 年 9 月期间,从英国诺丁汉大学医院的产前诊所或在线招募的目前吸烟的孕妇进行了二次数据分析。参与者设定了戒烟日期,接受了原型 NRT 依从性干预,并通过智能手机应用程序报告了 28 天内的每日香烟数(CPD)和每日 NRT 剂量(mg)。
共筛查了 388 名女性,32 名(8%)符合条件并参加了研究。24 名(75%)共提交了 510 次应用程序报告。17 名(71%)至少有一天同时报告吸烟和使用 NRT,在 109 次(21%)应用程序报告中有同时使用的情况。NRT 日剂量与 CPD 的关系遵循约 7%的指数衰减曲线。在使用 4 个线性样条(NRT 剂量 17、40 和 85mg 的结点)的多级重复测量模型中,观察到 NRT 剂量对 CPD 的固定效应在样条 1、3 和 4 上有显著差异。最强的关联是样条 1(0-17mg/NRT),其中每增加 10mg NRT,CPD 减少 0.6(平均减少 24%)。
在一项戒烟研究中,许多女性同时吸烟和使用 NRT;在这些女性中,日尼古丁剂量和吸烟量呈负相关。
这些发现对旨在减少与妊娠吸烟相关危害的未来干预措施的设计具有意义。它们表明,在怀孕期间同时使用 NRT 和吸烟可能有助于一些女性减少每天吸烟的数量。